Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Philippe Collet

Showing results (161-170 of 376) with videos related to

Pageof 38
Sort By:
JACC. Cardiovascular Interventions|May 26, 2009
Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized studyBoris Aleil, Laurent Jacquemin, Fabien De Poli, et al.
BMJ (Clinical Research Ed.)|May 9, 2015
Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysisAnne Bellemain-Appaix, Mathieu Kerneis, Stephen A O'Connor, et al.
European Heart Journal|July 2, 2010
Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION studyJohanne Silvain, Ana Pena, Guillaume Cayla, et al.
European Heart Journal|April 22, 2014
Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgeryMiguel Sousa-Uva, Robert Storey, Kurt Huber, et al.
Journal of the American College of Cardiology|January 23, 2004
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) studyMiles Dalby, Gilles Montalescot, Claire Bal dit Sollier, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 22, 2021
Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysisThomas Mouyen, Thibaut Manigold, Jean-Philippe Collet, et al.
European Heart Journal|September 27, 2013
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary interventionDániel Aradi, Robert F Storey, András Komócsi, et al.
BMJ (Clinical Research Ed.)|February 7, 2012
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysisJohanne Silvain, Farzin Beygui, Olivier Barthélémy, et al.
Heart (British Cardiac Society)|July 28, 2011
Non-cardiac surgery in patients with coronary stents: the RECO studyPierre Albaladejo, Emmanuel Marret, Charles-Marc Samama, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 20, 2009
Long-term outcome after bare-metal or drug-eluting stenting for allograft coronary artery diseaseFarzin Beygui, Shaida Varnous, Gilles Montalescot, et al.
Pageof 38

Showing results (161-170 of 376) with videos related to

Sort By:
Pageof 38
JACC. Cardiovascular Interventions|May 26, 2009
Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized studyBoris Aleil, Laurent Jacquemin, Fabien De Poli, et al.
BMJ (Clinical Research Ed.)|May 9, 2015
Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysisAnne Bellemain-Appaix, Mathieu Kerneis, Stephen A O'Connor, et al.
European Heart Journal|July 2, 2010
Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION studyJohanne Silvain, Ana Pena, Guillaume Cayla, et al.
European Heart Journal|April 22, 2014
Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgeryMiguel Sousa-Uva, Robert Storey, Kurt Huber, et al.
Journal of the American College of Cardiology|January 23, 2004
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) studyMiles Dalby, Gilles Montalescot, Claire Bal dit Sollier, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 22, 2021
Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysisThomas Mouyen, Thibaut Manigold, Jean-Philippe Collet, et al.
European Heart Journal|September 27, 2013
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary interventionDániel Aradi, Robert F Storey, András Komócsi, et al.
BMJ (Clinical Research Ed.)|February 7, 2012
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysisJohanne Silvain, Farzin Beygui, Olivier Barthélémy, et al.
Heart (British Cardiac Society)|July 28, 2011
Non-cardiac surgery in patients with coronary stents: the RECO studyPierre Albaladejo, Emmanuel Marret, Charles-Marc Samama, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 20, 2009
Long-term outcome after bare-metal or drug-eluting stenting for allograft coronary artery diseaseFarzin Beygui, Shaida Varnous, Gilles Montalescot, et al.
Pageof 38